Related Experiment Video
Updated: Jun 6, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Tarka® overdose in a young child
Murat Doğan1, Murat Basaranoglu, Erdal Peker
1Department of Pediatrics, Yuzuncu Yil University, School of Medicine, Van, Türkiye. doganmurat.md@gmail.com
Insights
Accidental ingestion of Tarka®, a verapamil and trandolapril combination, caused severe hypotension and bradycardia in a young child. A temporary pacemaker restored normal heart rhythm, highlighting potential toxicity risks in pediatric patients.
Area of Science:
- Cardiology
- Pediatric Toxicology
Background:
- Tarka® is a fixed-dose combination of verapamil hydrochloride and trandolapril used for hypertension.
- Pediatric data on Tarka® overdose is scarce.
Observation:
- A 3.5-year-old child ingested six Tarka® tablets, leading to lethargy and progressive hypotension.
- Despite medical treatment, the child's condition deteriorated, requiring intervention.
Findings:
- The patient required a temporary pacemaker implantation due to severe bradycardia and hypotension.
- Vital signs normalized post-pacemaker implantation, with successful removal after 13 hours.
Implications:
- This case highlights the potential for severe toxicity from Tarka® in young children.
- Lethargy can be an early sign of clinical deterioration in pediatric overdose cases.
- Understanding toxic doses is crucial for managing accidental pediatric ingestions of combination antihypertensives.
Abstract:
Tarka® is a combination antihypertensive medication composed of verapamil hydrochloride and trandolapril. A 3.5-year-old female was brought to our hospital due to a sleepy condition 7 hours after an accidental ingestion of six tablets of Tarka® containing 240 mg verapamil hydrochloride and 4 mg trandolapril in each tablet. Five hours after hospitalization, her condition deteriorated and arterial pressure progressively decreased despite the treatment. Finally, a temporary pacemaker was implanted, after which the vital findings began to return to normal values. The pacemaker was removed 13 hours after implantation as normal heart rhythm was observed. There are no reports of intoxication with fixed-dose combination products, especially Tarka®, in young children in the literature. Therefore, we believe that our report can provide an insight on the toxic dose of this drug in younger children. Clinicians should keep in mind that lethargy can be the first symptom of a possible clinical deterioration, even in normotensive and normorhythmic individuals.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Dose-Dependent Reactions
Pharmaceutical Poisoning: Potential Scenarios
Drug Toxicity: Risk factors
Drug Toxicity: Overview
